Reducing cardiovascular risk in high-risk patients with diabetes/metabolic syndrome

被引：0
作者：
Weissman, Peter [1 ,2 ]
Davidson, Michael [3 ]
机构：
[1] Univ Miami, Sch Med, Internal Med Endocrinol, Coral Gables, FL 33124 USA
[2] Osteoporosis Ctr, Miami, FL USA
[3] Univ Chicago, Pritzker Sch Med, Prevent Cardiol, Chicago, IL 60637 USA
来源：
POST ACCORD PERSPECTIVES: THE ROLE OF FENOFIBRATES: TRANSLATING THE EVIDENCE-BASED MEDICINE AND SCIENCE INTO CLINICAL PRACTICE FOR THE PRIMARY CARE PROVIDER | 2010年 / 274卷
关键词：
EXTREMITY ARTERIAL-DISEASE; TERM FENOFIBRATE THERAPY; TYPE-2; DIABETES-MELLITUS; ATHEROSCLEROSIS INTERVENTION; METABOLIC-SYNDROME; DOUBLE-BLIND; 9795; PEOPLE; MEN; BEZAFIBRATE; PREVENTION;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：26 / 42
页数：17
相关论文
共 50 条
[31]   Association of Metabolic Syndrome and Hyperferritinemia in Patients at Cardiovascular Risk [J].
Tofano, Ricardo Jose ;
Pescinni-Salzedas, Leticia Maria ;
Baisi Chagas, Eduardo Federighi ;
Penteado Detregiachi, Claudia Rucco ;
Guiguer, Elen Landgraf ;
Araujo, Adriano Cressoni ;
Bechara, Marcelo Dib ;
Rubira, Claudio Jose ;
Barbalho, Sandra Maria .
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2020, 13 :3239-3248
[32]   Pharmacological approach to cardiovascular risk in metabolic syndrome [J].
Bellis, Alessandro ;
Trimarco, Bruno .
JOURNAL OF CARDIOVASCULAR MEDICINE, 2013, 14 (06) :403-409
[33]   Interrelationships with Metabolic Syndrome, Obesity and Cardiovascular Risk [J].
Said, Sarmad ;
Mukherjee, Debabrata ;
Whayne, Thomas F., Jr. .
CURRENT VASCULAR PHARMACOLOGY, 2016, 14 (05) :415-425
[34]   Metabolic and cardiovascular risk factors in Klinefelter syndrome [J].
Spaziani, Matteo ;
Radicioni, Antonio F. .
AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS, 2020, 184 (02) :334-343
[35]   Hypertensive patients and diabetes: A high-risk population [J].
Bilo, HJG ;
Gans, ROB .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1998, 32 :S1-S8
[36]   Potential Impact of Metabolic Syndrome Control on Cardiovascular Risk in Elderly Patients with Diabetes: A Cross-Sectional Study [J].
Nascimento, Tania ;
Espirito-Santo, Margarida ;
Goncalves, Adriana ;
Pinto, Ezequiel ;
De Sousa-Coelho, Ana Luisa ;
Estevao, Maria Dulce .
DIABETOLOGY, 2024, 5 (03) :321-332
[37]   The interplay of cardiovascular risk factors in the metabolic syndrome and type 2 diabetes [J].
Betteridge, DJ .
EUROPEAN HEART JOURNAL SUPPLEMENTS, 2004, 6 (0G) :G3-G7
[38]   Management of Cardiovascular Risk Associated with Insulin Resistance, Diabetes, and the Metabolic Syndrome [J].
Mehta, Adi .
POSTGRADUATE MEDICINE, 2010, 122 (03) :61-70
[39]   Biologics for Reducing Cardiovascular Risk in Psoriasis Patients [J].
Terui, Hitoshi ;
Asano, Yoshihide .
JOURNAL OF CLINICAL MEDICINE, 2023, 12 (03)
[40]   Cardiovascular risk assessment in patients with type 2 diabetes mellitus and metabolic syndrome: Role of biomarkers [J].
Kanbak, Gungor ;
Akalin, Aysen ;
Dokumacioglu, Ali ;
Ozcelik, Eda ;
Bal, Cengiz .
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2011, 5 (01) :7-11
12345